Justin J. McAnear, Chief Financial Officer at 10x Genomics, Inc. (TXG), sold 15,300 shares at $145.54 ($2.3M) on 2021-12-01, disclosed to the SEC on 2021-12-03.
Open-market sale of $2.3M TXG by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $145.54 | 2,462 | $358K | 15.9% |
| 2 | $145.54 | 2,462 | $358K | 15.9% |
| 3 | $146.49 | 1,536 | $225K | 10.0% |
| 4 | $146.49 | 1,536 | $225K | 10.0% |
| 5 | $147.62 | 2,700 | $399K | 17.7% |
| 6 | $148.48 | 1,302 |
| $193K |
| 8.6% |
| 7 | $148.48 | 1,302 | $193K | 8.6% |
| 8 | $149.41 | 600 | $90K | 4.0% |
| 9 | $150.71 | 500 | $75K | 3.3% |
| 10 | $151.31 | 300 | $45K | 2.0% |
| 11 | $151.80 | 300 | $46K | 2.0% |
| 12 | $153.86 | 200 | $31K | 1.4% |
| 13 | $155.55 | 100 | $16K | 0.7% |
| Total | $147.33 avg | 15,300 | $2.3M | 100% |
| Filing → |
| TXG | SELL | 2024-02-26 | $173K | — | Filing → |
| TXG | SELL | 2023-11-27 | $146K | — | Filing → |
| TXG | SELL | 2023-08-24 | $154K | — | Filing → |